Payer PolicyActive
CG-SURG-101 Ablative Techniques as a Treatment for Barrettâs Esophagus
ANTHEM-CG-SURG-101
Anthem
Effective: July 1, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses endoscopic ablative techniques for Barrett’s esophagus, specifically radiofrequency ablation (RFA) and cryoablation. Ablation is covered as medically necessary only when pathology confirms high-grade dysplasia (HGD) or intramucosal cancer (IMC) and all policy criteria are met; it is not covered if these criteria are not met or for any other indications. Electrocoagulation, argon plasma coagulation, and laser ablation are considered not medically necessary in all circumstances.
Coverage Criteria Preview
Key requirements from the full policy
"I."
Sign up to see full coverage criteria, indications, and limitations.